| Primary |
| Product Used For Unknown Indication |
33.8% |
| Drug Use For Unknown Indication |
27.3% |
| Seasonal Allergy |
6.1% |
| Pruritus |
3.6% |
| Hypersensitivity |
3.4% |
| Foetal Exposure During Pregnancy |
3.2% |
| Rhinitis Allergic |
2.5% |
| Pulmonary Hypertension |
2.2% |
| Urticaria |
2.2% |
| Multiple Allergies |
1.8% |
| Prophylaxis |
1.8% |
| Asthma |
1.7% |
| Eczema |
1.6% |
| Hypertension |
1.6% |
| Cardiac Failure |
1.3% |
| Chronic Spontaneous Urticaria |
1.2% |
| Granuloma Annulare |
1.2% |
| Pain |
1.2% |
| Rash |
1.2% |
| Acarodermatitis |
1.1% |
|
| Drug Exposure During Pregnancy |
28.9% |
| Urticaria |
6.3% |
| Abortion Spontaneous |
5.7% |
| Rash |
5.7% |
| Somnolence |
5.7% |
| Wrong Drug Administered |
5.0% |
| Liver Function Test Abnormal |
4.4% |
| Platelet Count Decreased |
4.4% |
| Convulsion |
3.8% |
| Off Label Use |
3.8% |
| Torsade De Pointes |
3.8% |
| Rhinorrhoea |
3.1% |
| Cholestasis |
2.5% |
| Musculoskeletal Discomfort |
2.5% |
| Pyrexia |
2.5% |
| Stevens-johnson Syndrome |
2.5% |
| Suicide Attempt |
2.5% |
| Tremor |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Diarrhoea |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
42.9% |
| Chronic Spontaneous Urticaria |
10.4% |
| Drug Use For Unknown Indication |
8.9% |
| Hypertension |
5.0% |
| Seasonal Allergy |
4.3% |
| Foetal Exposure During Pregnancy |
3.5% |
| Urticaria |
2.9% |
| Pulmonary Hypertension |
2.2% |
| Asthma |
2.0% |
| Drug Exposure In Utero |
2.0% |
| Hypersensitivity |
1.9% |
| Multiple Allergies |
1.9% |
| Pruritus |
1.9% |
| Influenza Like Illness |
1.7% |
| Pain |
1.7% |
| Prophylaxis |
1.7% |
| Rhinitis Allergic |
1.7% |
| Acute Myocardial Infarction |
1.2% |
| Muscle Spasms |
1.2% |
| Systemic Lupus Erythematosus |
1.2% |
|
| Convulsion |
9.0% |
| Urticaria |
9.0% |
| Therapeutic Response Decreased |
8.0% |
| Accidental Overdose |
6.0% |
| Drug Exposure During Pregnancy |
6.0% |
| Rash |
6.0% |
| Suicide Attempt |
6.0% |
| Wrong Drug Administered |
6.0% |
| Off Label Use |
5.0% |
| Tremor |
5.0% |
| Vestibular Disorder |
5.0% |
| Exposure During Pregnancy |
4.0% |
| Weight Decreased |
4.0% |
| Drug Ineffective |
3.0% |
| Dyspnoea |
3.0% |
| Insomnia |
3.0% |
| Liver Function Test Abnormal |
3.0% |
| Platelet Count Decreased |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Tubulointerstitial Nephritis |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.3% |
| Product Used For Unknown Indication |
9.1% |
| Rheumatoid Arthritis |
8.6% |
| Asthma |
8.3% |
| Hypersensitivity |
6.7% |
| Hypertension |
5.2% |
| Prophylaxis |
3.6% |
| Crohn's Disease |
3.1% |
| Pain |
2.9% |
| Psoriasis |
2.7% |
| Seasonal Allergy |
2.6% |
| Hiv Infection |
2.5% |
| Depression |
2.2% |
| Blood Cholesterol Increased |
2.1% |
| Vitamin Supplementation |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Diabetes Mellitus |
1.7% |
| Psoriatic Arthropathy |
1.6% |
| Type 2 Diabetes Mellitus |
1.4% |
| Insomnia |
1.3% |
|
| Pruritus |
9.1% |
| Weight Decreased |
8.2% |
| Urticaria |
7.4% |
| Drug Ineffective |
7.0% |
| Vomiting |
6.6% |
| Weight Increased |
6.2% |
| Pain |
5.3% |
| Incorrect Dose Administered |
4.9% |
| Paraesthesia |
4.5% |
| Flushing |
4.1% |
| Injection Site Pain |
4.1% |
| Myalgia |
4.1% |
| Pyrexia |
4.1% |
| Accidental Exposure |
3.7% |
| Rash |
3.7% |
| Urinary Tract Infection |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Pancreatitis |
3.3% |
| Rash Pruritic |
3.3% |
| Drug Exposure During Pregnancy |
2.9% |
|
| Interacting |
| Bipolar Disorder |
50.0% |
| Contraception |
25.0% |
| Seasonal Allergy |
25.0% |
|
| Unintended Pregnancy |
100.0% |
|
